That’s according to George Paraskevakos, the executive director of the International Probiotics Association.
We caught up with Paraskevakos on camera after his presentation at our recent Probiota Asia Summit in Singapore.
In the video he shares insights from a new consumer survey undertaken by the association, plus the very latest regional market data.
He also assesses the current regulatory landscape and explains the important of a new clinical trails database compiled by the association.
Watch the video for more.
